Search Results - "Vorselaars, Adm"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis by Vorselaars, Adriane D.M., MD, Wuyts, Wim A., MD, PhD, Vorselaars, Veronique M.M., MD, Zanen, Pieter, MD, PhD, Deneer, Vera H.M., PhD, Veltkamp, Marcel, MD, PhD, Thomeer, Michiel, MD, PhD, van Moorsel, Coline H.M., PhD, Grutters, Jan C., MD, PhD

    Published in Chest (01-09-2013)
    “…Background Steroids remain the first-choice therapeutic in sarcoidosis; however, long-term use is associated with toxicity. Evidence defining the best…”
    Get full text
    Journal Article
  2. 2

    Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis by Schimmelpennink, M C, Quanjel, M, Vorselaars, Adm, Wiertz, I, Veltkamp, M, Van Moorsel, Chm, Grutters, J C

    Published in Expert review of respiratory medicine (02-07-2020)
    “…Differentiating between interstitial lung diseases (ILD) is challenging. Serum soluble interleukin 2 receptor (sIL-2R) is used as a diagnostic marker in…”
    Get more information
    Journal Article
  3. 3

    Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis by Verwoerd, A., Hijdra, D., Vorselaars, A. D. M., Crommelin, H. A., van Moorsel, C. H. M., Grutters, J. C., Claessen, A. M. E.

    Published in Clinical and experimental immunology (01-08-2016)
    “…Summary Sarcoidosis is a systemic granulomatous disease of unknown aetiology that most commonly affects the lungs. Although elevated levels of regulatory T…”
    Get full text
    Journal Article